Hanlim wins 2nd trial for Allergan’s ‘Combigan’ composition patent, too

Hanlim Pharm, which filed the nullification trial of the glaucoma-treating ‘Combigan’ composition patent, won the 2^nd trial, too, against Allergan owning the original product.

This winning has raise the chance for Hanlim Pharm to acquire the 9-month exclusive sale right of its generic from the nullification of the composition patent under the Patent Linkage System.

The 22^nd Division of the Pa...